Abstract:Efficient and accurate methods to estimate insulin sensitivity (SI) and β-cell function (BCF) are of great importance for studying the pathogenesis and treatment effectiveness of type 2 diabetes (T2D). Existing methods range in sensitivity, input data, and technical requirements. Oral glucose tolerance tests (OGTTs) are preferred because they are simpler and more physiological than intravenous methods. However, current analytical methods for OGTT-derived SI and BCF also range in complexity; the oral minimal models require mathematical expertise for deconvolution and fitting differential equations, and simple algebraic surrogate indices (e.g., Matsuda index, insulinogenic index) may produce unphysiological values. We developed a new insulin secretion and sensitivity (ISS) model for clinical research that provides precise and accurate estimates of SI and BCF from a standard OGTT, focusing on effectiveness, ease of implementation, and pragmatism. This model was developed by fitting a pair of differential equations to glucose and insulin without need of deconvolution or C-peptide data. This model is derived from a published model for longitudinal simulation of T2D progression that represents glucose-insulin homeostasis, including postchallenge suppression of hepatic glucose production and first- and second-phase insulin secretion. The ISS model was evaluated in three diverse cohorts across the lifespan. The new model had a strong correlation with gold-standard estimates from intravenous glucose tolerance tests and insulin clamps. The ISS model has broad applicability among diverse populations because it balances performance, fidelity, and complexity to provide a reliable phenotype of T2D risk.NEW & NOTEWORTHY The pathogenesis of type 2 diabetes (T2D) is determined by a balance between insulin sensitivity (SI) and β-cell function (BCF), which can be determined by gold standard direct measurements or estimated by fitting differential equation models to oral glucose tolerance tests (OGTTs). We propose and validate a new differential equation model that is simpler to use than current models and requires less data while maintaining good correlation and agreement with gold standards. Matlab and Python code is freely available.

Leptin augmented model to include the role of obesity in insulin-glucose regulatory system for T2DM subjects

Parameter estimation for the oral minimal model and parameter distinctions between obese and non-obese type 2 diabetes

A Mathematical Model for Assessing How Obesity-Related Factors Aggravate Diabetes

Glucose-insulin mathematical model for the combined effect of medications and life style of Type 2 diabetic patients

Dynamical modeling the effect of glucagon-like peptide on glucose-insulin regulatory system based on mice experimental observation

Dynamics of a New Delayed Glucose–Insulin Model with Obesity

Estimating insulin sensitivity and β-cell function from the oral glucose tolerance test: validation of a new insulin sensitivity and secretion (ISS) model

Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothing

Leveraging continuous glucose monitoring for personalized modeling of insulin-regulated glucose metabolism

A parsimonious model of blood glucose homeostasis

A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects

A Hypothalamic Leptin-Glutamate Interaction in the Regulation of Sympathetic Nerve Activity

The Lipids and Volume in Satiation and Satiety (LIVES) Hypothesis: A Proposed Alternative Model for the Pathogenesis of Obesity

Modeling Leptin Receptor Insensitivity by Comparing How Leptin or Leptin Receptor Mutations in Mice Affect Body Weight, Basal Metabolism, Body Temperature and Feeding Behaviors

Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity model

A Mathematical Model-Derived Disposition Index Without Insulin Validated in Youth with Obesity

Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance

A Mechanistic Model of Gut–Brain Axis Perturbation and High-Fat Diet Pathways to Gut Microbiome Homeostatic Disruption, Systemic Inflammation, and Type 2 Diabetes

Leptin and Obesity: Role and Clinical Implication

Modeling Glucose, Insulin, C-Peptide, and Lactate Interplay in Adolescents During an Oral Glucose Tolerance Test

Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test